Using single-cell sequencing technology to detect circulating tumor cells in solid tumors

Mol Cancer. 2021 Aug 19;20(1):104. doi: 10.1186/s12943-021-01392-w.

Abstract

Circulating tumor cells are tumor cells with high vitality and high metastatic potential that invade and shed into the peripheral blood from primary solid tumors or metastatic foci. Due to the heterogeneity of tumors, it is difficult for high-throughput sequencing analysis of tumor tissues to find the genomic characteristics of low-abundance tumor stem cells. Single-cell sequencing of circulating tumor cells avoids interference from tumor heterogeneity by comparing the differences between single-cell genomes, transcriptomes, and epigenetic groups among circulating tumor cells, primary and metastatic tumors, and metastatic lymph nodes in patients' peripheral blood, providing a new perspective for understanding the biological process of tumors. This article describes the identification, biological characteristics, and single-cell genome-wide variation in circulating tumor cells and summarizes the application of single-cell sequencing technology to tumor typing, metastasis analysis, progression detection, and adjuvant therapy.

Keywords: Circulating tumor cells; Research progress; Single-cell sequencing; Tumor heterogeneity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor*
  • Flow Cytometry
  • Gene Expression Profiling
  • Genetic Heterogeneity
  • Genomics / methods
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Neoplasms / diagnosis*
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Neoplastic Cells, Circulating / metabolism*
  • Neoplastic Stem Cells / metabolism
  • Single-Cell Analysis* / methods
  • Transcriptome

Substances

  • Biomarkers, Tumor